ECTRIMS eLearning

Cognitive decline and every day activities in secondary progressive multiple sclerosis. The role of third ventricle width
Author(s): ,
A Papathanasiou
Affiliations:
Department of Neurology, Queen's Medical Centre, Nottingham University Hospitals NHS Trust, Nottingham, United Kingdom;Department of Neurology, Neuropsychology Section, University of Patras Medical School
,
L Messinis
Affiliations:
Department of Neurology, Neuropsychology Section, University of Patras Medical School
,
P Zampakis
Affiliations:
Department of Radiology, University of Patras Medical School, Patras, Greece
P Papathanasopoulos
Affiliations:
Department of Neurology, Neuropsychology Section, University of Patras Medical School
ECTRIMS Learn. Papathanasiou A. 09/14/16; 145560; EP1465
Athanasios Papathanasiou
Athanasios Papathanasiou
Contributions
Abstract

Abstract: EP1465

Type: ePoster

Abstract Category: Pathology and pathogenesis of MS - Neuropsychology

Introduction: Cognitive impairment is an important predictor of quality of life at all stages of Multiple Sclerosis (MS). Magnetic Resonance Imaging (MRI) markers have been used to associate tissue damage with cognitive dysfunction.

Objective: The aim of the study was to designate the MRI marker that predicts cognitive decline and explore its effect on every day activities in SPMS patients.

Methods: 30 SPMS patients and 31 healthy participants underwent neuropsychological assessment using the Trail Making Test (TMT) parts A and B, semantic and phonological verbal fluency task and a computerized cognitive screening battery (Central Nervous System Vital Signs). Everyday activities were evaluated with the instrumental activities of daily living (IADL) scale. Brain MRI was performed in all participants. We measured total lesion volume, third ventricle width, corpus callosum and thalamic area.

Comparisons between RRMS and controls were investigated on each neuropsychological and MRI measure using t-test and Mann-Whitney U test. Pearson correlation coefficients and Spearman rank correlation coefficients were calculated for all measures in both groups. We conducted a stepwise regression analysis using as dependent variable the IADL. We then used as dependent variables the neuropsychological measures that appeared from the previous regressions to be the best predictors for IADL, and proceeded with a stepwise analysis using all MRI measures as independent variables.

Results: The frequency of cognitive dysfunction for our SPMS patients was 80%. SPMS patients differed significantly from controls on all neuropsychological measures. Third ventricle width had a correlation with phonological verbal fluency task, processing speed, cognitive flexibility and executive functions. Phonological verbal fluency task, processing speed and psychomotor speed were the most sensitive markers for IADL.

Third ventricle width was the most sensitive MRI marker for processing speed and phonological verbal fluency task.

Conclusion: Third ventricle width predicts the clinically meaningful cognitive decline in our SPMS patients.

Disclosure:

Athanasios Papathanasiou: nothing to disclose

Lambros Messinis: nothing to disclose

Petros Zampakis: nothing to disclose

Panagiotis Papathanasopoulos: nothing to disclose

Abstract: EP1465

Type: ePoster

Abstract Category: Pathology and pathogenesis of MS - Neuropsychology

Introduction: Cognitive impairment is an important predictor of quality of life at all stages of Multiple Sclerosis (MS). Magnetic Resonance Imaging (MRI) markers have been used to associate tissue damage with cognitive dysfunction.

Objective: The aim of the study was to designate the MRI marker that predicts cognitive decline and explore its effect on every day activities in SPMS patients.

Methods: 30 SPMS patients and 31 healthy participants underwent neuropsychological assessment using the Trail Making Test (TMT) parts A and B, semantic and phonological verbal fluency task and a computerized cognitive screening battery (Central Nervous System Vital Signs). Everyday activities were evaluated with the instrumental activities of daily living (IADL) scale. Brain MRI was performed in all participants. We measured total lesion volume, third ventricle width, corpus callosum and thalamic area.

Comparisons between RRMS and controls were investigated on each neuropsychological and MRI measure using t-test and Mann-Whitney U test. Pearson correlation coefficients and Spearman rank correlation coefficients were calculated for all measures in both groups. We conducted a stepwise regression analysis using as dependent variable the IADL. We then used as dependent variables the neuropsychological measures that appeared from the previous regressions to be the best predictors for IADL, and proceeded with a stepwise analysis using all MRI measures as independent variables.

Results: The frequency of cognitive dysfunction for our SPMS patients was 80%. SPMS patients differed significantly from controls on all neuropsychological measures. Third ventricle width had a correlation with phonological verbal fluency task, processing speed, cognitive flexibility and executive functions. Phonological verbal fluency task, processing speed and psychomotor speed were the most sensitive markers for IADL.

Third ventricle width was the most sensitive MRI marker for processing speed and phonological verbal fluency task.

Conclusion: Third ventricle width predicts the clinically meaningful cognitive decline in our SPMS patients.

Disclosure:

Athanasios Papathanasiou: nothing to disclose

Lambros Messinis: nothing to disclose

Petros Zampakis: nothing to disclose

Panagiotis Papathanasopoulos: nothing to disclose

By clicking “Accept Terms & all Cookies” or by continuing to browse, you agree to the storing of third-party cookies on your device to enhance your user experience and agree to the user terms and conditions of this learning management system (LMS).

Cookie Settings
Accept Terms & all Cookies